Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Roswell Park Cancer Institute, Buffalo

NEXT Virginia, Fairfax

Cancer Treatment Centers of America - Atlanta, Atlanta

Mount Sinai Comprehensive Cancer Center, Miami Beach

Tennessee Oncology, Nashville

Vanderbilt Ingram Cancer Center, Nashville

Ohio State University, Columbus

Mayo Clinic, Rochester

Cancer Treatment Centers of America - Chicago, Zion

Robert H. Lurie Comprehensive Cancer Center of Northwestern Univeristy, Chicago

Washington University School of Medicine - Siteman Cancer Center, St Louis

University of Nebraska Medical Center, Omaha

The University of Texas MD Anderson Cancer Center, Houston

NEXT Oncology, San Antonio

Sarah Cannon Research Institute at HealthONE, Denver

Cancer Treatment Centers of America - Phoenix, Goodyear

California Cancer Associates for Research and Excellence (cCARE), Encinitas

University of California, San Diego, La Jolla

Fred Hutchinson Cancer Center, Seattle

Seoul National University Hospital, Seoul

Severance Hospital Yonsei University Health System - PPDS, Seoul

Samsung Medical Center, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul